BACKGROUND: Recent reports have indicated that autonomic tone fluctuations measured by heart rate variability (HRV) precede episodes of paroxysmal atrial fibrillation (AF). Little is known about the impact of baseline autonomic tone and the development of new onset AF in a population-based cohort. The purpose of this study was to assess the role of HRV as a predictor of new onset AF. METHOD: Ambulatory ECG recordings obtained from the Framingham Heart Study subjects attending a routine examination were processed for HRV. The HRV variables analyzed included standard deviation of normal R-R intervals (SDNN), low frequency power (LF), high frequency power (HF), and LF/HF ratio. There were 1434 women and 1142 men (54 +/- 14.1 years) eligible for the study. RESULTS: In 12 years of follow-up, 65 women and 67 men had new onset AF. The study had 80% power to detect a hazard ratio (HR) of 1.3 per standard deviation (SD) decrement in HRV. A one SD decrement in log LF/HF was associated with increased risk of developing AF (HR = 1.23; 95% confidence intervals (CI) = 1.06-1.44) in age- and sex-adjusted models; the association was no longer significant (HR = 1.15; 95% CI = 0.98-1.35) after adjusting for potential confounders. CONCLUSION: Autonomic dysregulation at baseline, as reflected by an altered HRV is associated with risk of AF; however, this association does not persist after adjusting for potential confounders. Much of the apparent association between HRV and AF is mediated by traditional risk factors.
BACKGROUND: Recent reports have indicated that autonomic tone fluctuations measured by heart rate variability (HRV) precede episodes of paroxysmal atrial fibrillation (AF). Little is known about the impact of baseline autonomic tone and the development of new onset AF in a population-based cohort. The purpose of this study was to assess the role of HRV as a predictor of new onset AF. METHOD: Ambulatory ECG recordings obtained from the Framingham Heart Study subjects attending a routine examination were processed for HRV. The HRV variables analyzed included standard deviation of normal R-R intervals (SDNN), low frequency power (LF), high frequency power (HF), and LF/HF ratio. There were 1434 women and 1142 men (54 +/- 14.1 years) eligible for the study. RESULTS: In 12 years of follow-up, 65 women and 67 men had new onset AF. The study had 80% power to detect a hazard ratio (HR) of 1.3 per standard deviation (SD) decrement in HRV. A one SD decrement in log LF/HF was associated with increased risk of developing AF (HR = 1.23; 95% confidence intervals (CI) = 1.06-1.44) in age- and sex-adjusted models; the association was no longer significant (HR = 1.15; 95% CI = 0.98-1.35) after adjusting for potential confounders. CONCLUSION: Autonomic dysregulation at baseline, as reflected by an altered HRV is associated with risk of AF; however, this association does not persist after adjusting for potential confounders. Much of the apparent association between HRV and AF is mediated by traditional risk factors.
Authors: H Tsuji; F J Venditti; E S Manders; J C Evans; M G Larson; C L Feldman; D Levy Journal: J Am Coll Cardiol Date: 1996-11-15 Impact factor: 24.094
Authors: M Fioranelli; M Piccoli; G M Mileto; F Sgreccia; P Azzolini; M P Risa; R L Francardelli; E Venturini; A Puglisi Journal: Pacing Clin Electrophysiol Date: 1999-05 Impact factor: 1.976
Authors: Sven Geurts; Martijn J Tilly; Banafsheh Arshi; Bruno H C Stricker; Jan A Kors; Jaap W Deckers; Natasja M S de Groot; M Arfan Ikram; Maryam Kavousi Journal: Clin Res Cardiol Date: 2022-08-13 Impact factor: 6.138
Authors: Brian B Koo; Reena Mehra; Terri Blackwell; Sonia Ancoli-Israel; Katie L Stone; Susan Redline Journal: J Clin Sleep Med Date: 2014-01-15 Impact factor: 4.062
Authors: Mohammadali Habibi; Harjit Chahal; Philip Greenland; Eliseo Guallar; João A C Lima; Elsayed Z Soliman; Alvaro Alonso; Susan R Heckbert; Saman Nazarian Journal: Am J Cardiol Date: 2019-09-06 Impact factor: 2.778
Authors: Sunil K Agarwal; Faye L Norby; Eric A Whitsel; Elsayed Z Soliman; Lin Y Chen; Laura R Loehr; Valentin Fuster; Gerardo Heiss; Josef Coresh; Alvaro Alonso Journal: J Am Coll Cardiol Date: 2017-01-24 Impact factor: 24.094